SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-19-000052
Filing Date
2019-08-09
Accepted
2019-08-09 16:16:05
Documents
64
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2019q2bhvn10-q.htm   iXBRL 10-Q 1221154
2 EXHIBIT 31.1 a2019q2bhvn10-qexhibit311.htm EX-31.1 13563
3 EXHIBIT 31.2 a2019q2bhvn10-qexhibit312.htm EX-31.2 13534
4 EXHIBIT 32.1 a2019q2bhvn10-qexhibit321.htm EX-32.1 8815
  Complete submission text file 0001689813-19-000052.txt   5410534

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20190630.xsd EX-101.SCH 49220
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20190630_cal.xml EX-101.CAL 57185
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20190630_def.xml EX-101.DEF 175279
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20190630_lab.xml EX-101.LAB 518544
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20190630_pre.xml EX-101.PRE 295579
10 EXTRACTED XBRL INSTANCE DOCUMENT a2019q2bhvn10-q_htm.xml XML 841003
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 191013148
SIC: 2834 Pharmaceutical Preparations